FMP
Cybin Inc.
CYBN
AMEX
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.
0.37 USD
-0.0055 (-1.49%)
About
ceo
Mr. Douglas L. Drysdale
sector
Healthcare
industry
Biotechnology
website
https://www.cybin.com
exchange
AMEX
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.
CIK
0001833141
ISIN
CA23256X1006
CUSIP
23256X100
Address
100 King Street West
Phone
908 764 8385
Country
CA
Employee
50
IPO Date
Sep 13, 2019
Summary
CIK
0001833141
Exchange
AMEX
Industry
Biotechnology
Sector
Healthcare
CUSIP
23256X100
ISIN
CA23256X1006
Country
CA
Price
0.37
Beta
0.96
Volume Avg.
5.56M
Market Cap
157.11M
Shares
-
52-Week
0.21-0.738
DCF
0.21
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-1.68
P/B
-
Website
https://www.cybin.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest CYBN News
It looks like there's no news available.
